Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Implications of the Hippo Pathway Dysregulation in Uterine Leiomyosarcoma

ANASTASIOS KYRIAZOGLOU, DIONYSIOS J. PAPACHRISTOU, MYRTO MOUTAFI, ALEXANDRA PAPAKOSTA, ALKISTIS PAPATHEODORIDI, MARIA KAPARELOU, ANNA MARIA KORAKITI, MICHALIS LIONTOS, MELETIOS ATHANASIOS DIMOPOULOS and FLORA ZAGOURI
Anticancer Research August 2024, 44 (8) 3331-3336; DOI: https://doi.org/10.21873/anticanres.17152
ANASTASIOS KYRIAZOGLOU
1Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: tassoskyr{at}gmail.com
DIONYSIOS J. PAPACHRISTOU
2Department of Anatomy-Histology-Embryology, University of Patras, School of Medicine, Patras, Greece;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MYRTO MOUTAFI
1Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ALEXANDRA PAPAKOSTA
3Department of Genetics, Agios Savvas Anticancer Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ALKISTIS PAPATHEODORIDI
1Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARIA KAPARELOU
1Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANNA MARIA KORAKITI
1Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MICHALIS LIONTOS
1Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MELETIOS ATHANASIOS DIMOPOULOS
1Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FLORA ZAGOURI
1Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles
PreviousNext
Back to top

In this issue

Anticancer Research: 44 (8)
Anticancer Research
Vol. 44, Issue 8
August 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Implications of the Hippo Pathway Dysregulation in Uterine Leiomyosarcoma
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
10 + 5 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Implications of the Hippo Pathway Dysregulation in Uterine Leiomyosarcoma
ANASTASIOS KYRIAZOGLOU, DIONYSIOS J. PAPACHRISTOU, MYRTO MOUTAFI, ALEXANDRA PAPAKOSTA, ALKISTIS PAPATHEODORIDI, MARIA KAPARELOU, ANNA MARIA KORAKITI, MICHALIS LIONTOS, MELETIOS ATHANASIOS DIMOPOULOS, FLORA ZAGOURI
Anticancer Research Aug 2024, 44 (8) 3331-3336; DOI: 10.21873/anticanres.17152

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Implications of the Hippo Pathway Dysregulation in Uterine Leiomyosarcoma
ANASTASIOS KYRIAZOGLOU, DIONYSIOS J. PAPACHRISTOU, MYRTO MOUTAFI, ALEXANDRA PAPAKOSTA, ALKISTIS PAPATHEODORIDI, MARIA KAPARELOU, ANNA MARIA KORAKITI, MICHALIS LIONTOS, MELETIOS ATHANASIOS DIMOPOULOS, FLORA ZAGOURI
Anticancer Research Aug 2024, 44 (8) 3331-3336; DOI: 10.21873/anticanres.17152
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Inhibition of AP-1 Reduces CD46-mediated Invasion of Bladder and Colon Cancer Cells
  • Apoptotic Induction by 1,5-Diaryl-1,4-pentadien-3-one Derivatives in the HL60 Cell Line: In Vitro and In Silico Expression
  • Evaluation of Combined Treatment With Atorvastatin and SREBP2 Inhibitors Against Colorectal Cancer Cells Under Two-dimensional and Three-dimensional Culture Models
Show more Experimental Studies

Keywords

  • Uterine leiomyosarcoma
  • Hippo pathway
  • YAP1
  • prognosis
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire